Paul Robeson also had two grandchildren, David Robeson (19511998) and Susan Robeson (1953- ), who became a documentary filmmaker. In 1980, Susan Robeson ...
Name / Title
Company / Classification
Phones & Addresses
David Robeson President
ADVANCED HEALTH NETWORKS,INC Health/Allied Services
1501 N Broadway STE 210, Walnut Creek, CA 94596 9254720243
Us Patents
Apparatus And Methods For Minimally Invasive Obesity Treatment
Daniel H. Kim - Houston TX, US David J. Robeson - Dublin CA, US
International Classification:
A61B 17/12 A61B 18/18
US Classification:
606 41, 606153
Abstract:
Systems, apparatus, and methods for the treatment of obesity and/or gastro-esophageal reflux disease (GERD). An embodiment includes an implantable device having an adjustable curved portion configured for exerting a suitable mechanical force on one or more tissues or organs targeted for treatment. Embodiments of the device neuromodulate nerve tissue to effect treatment of obesity and/or GERD. Another embodiment includes an intraluminal guide for guiding placement of the implantable device in the patient.
Methods For Identifying Cercosporin-Degrading Microorganisms
David J. Robeson - Dublin CA Mahbubul A. F. Jalal - Lathrop CA Robert B. Simpson - Danville CA
International Classification:
C12Q 102 C12Q 104 C12N 138 C12N 112
US Classification:
435 29
Abstract:
Methods for the isolation and purification of the phytotoxin cercosporin are disclosed as well as methods for identifying microorganisms capable of degrading cercosporin. Cercosporin can be purified from members of the fungal genus Cercospora and incorporated into culture medium for selection of those organisms resistant to cercosporin. Once identified, these organisms can be used to isolate the protein and the gene responsible for conferring cercosporin-resistance. The gene can be cloned and inserted into a suitable expression vector so that the protein can be further characterized. Additionally, the DNA encoding for cercosporin-resistance can be inserted into a vector suitable for transforming an Agrobacterium and the Agrobacterium in turn used to transform plant cells normally susceptible to Cercospora infection. Plants can be regenerated from the transformed plant cells. In this way, a transgenic plant can be produced with the capability of degrading cercosporin.